Company information lookup

IMUGENE LIMITED (IMU)

An Australian pharmaceutical company with a platform drug delivery platform technology at the centre of its assets. The platform allows drugs in tablet form to be delivered straight into the blood stream via the mouth accelerating onset of action and reducing side effects of absorption in the stomach.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IMU 0.006 0% 0.006 0.008 0.007 0.007 0.006 70,000

ASX Find a broker tool

Helps you find an ASX broker based on your needs and where you live.

IMUGENE LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IMU
Securities
Official Listing Date 24 November, 1993
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.imugene.com
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3142
Head Office Telephone 03 9824 5254
Head Office Fax 03 9822 7735
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Steve Harris (Non Exec. Chairman)
Dr Nicholas Ede (Executive Director)
Mr Paul Hopper (Non Exec. Director)
Mr Phillip Hains (CFO)
Company Secretary Mr Justyn Stedwell
Mr Phillip Hains (Joint Co. Secretary)
Principal Activities An Australian pharmaceutical company with a platform drug delivery platform technology at the centre of its assets. The platform allows drugs in tablet form to be delivered straight into the blood stream via the mouth accelerating onset of action and reducing side effects of absorption in the stomach.

IMUGENE LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
08/05/2013   Research Report on Imugene Drug Delivery Technology 1 PDF
02/05/2013   Shareholder Newsletter 4 PDF
01/05/2013   Investor Presentation 15 PDF
30/04/2013 asterix Share Purchase Plan - Offer Document 21 PDF
30/04/2013 asterix Share Purchase Plan 2 PDF
30/04/2013   Share Purchase Plan - Cleansing Notice 1 PDF
30/04/2013 asterix Imugene granted Chinese patent 2 PDF
29/04/2013 asterix Appendix 4C - quarterly 5 PDF
05/03/2013 asterix Imugene to be awarded Japanese patent 2 PDF
28/02/2013 asterix Half Year Financial Results 2 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
22 May 2013 0.006 -14.29% 0.007 0.006 70,000
20 May 2013 0.007 -12.5% 0.007 0.007 171,908
17 May 2013 0.008 -11.11% 0.008 0.008 250,000
13 May 2013 0.009 0% 0.009 0.009 20,000
10 May 2013 0.009 12.5% 0.009 0.008 453,092

* Volume of shares shown represents only those shares traded on ASX.

IMUGENE LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IMU. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IMU

Warrants & Structured Products

No warrants & Structured Products are available over the security IMU

ASX CFDs

No Contracts For Differences are available over the security IMU